April - 2022

NEWS

Ymmunobio to Present at the Annual Meeting of the Association for Cancer Immunotherapy (CIMT)

Ymmunobio Appoints New Chief Operating Officer

Ymmunobio Accepted into Innosuisse Core Coaching

Dr. Katrin Rupalla Interviewed by Global Business Reports

Drug Discovery & Development

Fierce Biotech: Appointment of Michel Janicot

PharmTech

Ymmunobio AG Signs Patent Purchase Agreement with LeukoGmbH https://www.pharmtech.com/view/ymmunobio-ag-signs-patent-purchase-agreement-w...

Ymmunobio AG Signs Patent Purchase Agreement with LeukoCom GmbH

Agreement expands the company strategy to employ the immune system in the development of cancer therapies RIEHEN, SWITZERLAND, April 7,...